Semaglutide can lose potency or become unsafe with longer exposure to room temperatures
Sci Rep 5:13752
The Link Between Saxenda and Gout: What the Evidence Shows There is no established direct causal link between Saxenda and gout based on current clinical evidence and regulatory data from the MHRA and EMA
In November 2025, Novo Nordisk lowered its standard self-pay price for most doses of Wegovy and Ozempic to $349 per month, with a limited-time introductory price of $199 per month for new self-pay patients on the two lowest doses
Using a lower dose outside of established medical guidelines is not the answer, said Velazquez
Compounded Medication Safety Notice: The FDA has identified concerns involving compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent products, adverse-event reports, and semaglutide salt forms